CoChat

Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor

Open access
Li, Chong, Cao, Jing, Zhang, Ning, Tu, Meiqing, Xu, Fengwei, Wei, Shuang, Chen, Xiaojing, Xu, Yuhong · 2018 · Scientific Reports
Cited by 51

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Cancers are driven by a variety of somatic gene mutations and identifying these mutations enables the development of novel target drugs. We have sought to identify abnormalities in Wnt pathway-related genes that are sensitive to Wnt inhibitor treatment. We examined Patient Derived Xenograft (PDX) RNA samples and found new R-Spondin 2 (RSPO2) transcript fusions with the EMC2, PVT1 or HNF4G genes. These fusion events were identified in about 1.4% of the digestive system cancer samples. We then examined the oncogenic effects of the RSPO2-EMC2 fusion gene and confirmed that it can drive oncogenesis, sustain tumor growth and promote metastasis. Finally, we used a Wnt pathway Porcupine inhibitor CGX1321 to treat PDX mouse models containing RSPO2 fusion genes. All the RSPO2 fusion tumors responded to the treatment and stopped progression. Our data show that Wnt pathway inhibition could provide an effective treatment for cancers containing RSPO2 fusion. The RSPO2 fusion will serve as a good biomarker for screening patients to support clinical treatment of digestive system cancers using Wnt pathway inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-32652-3

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 51

Metadata

Authors
Li, C., Cao, J., Zhang, N., Tu, M., Xu, F., Wei, S., Chen, X., & Xu, Y.
Venue
Scientific Reports
Published
2018-09-24
Volume
8
Issue
1
Pages
14244-14244
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2891828924
Cited by
51
References
8
FWCI
1.65
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor. https://app.cochat.ai/papers/10.1038/s41598-018-32652-3
The paper
Li, C., Cao, J., Zhang, N., Tu, M., Xu, F., Wei, S., Chen, X., & Xu, Y. (2018). Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor. Scientific Reports. https://doi.org/10.1038/s41598-018-32652-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.